Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Vo

Showing results (81-90 of 143) with videos related to

Pageof 15
Sort By:
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|November 2, 2007
Analysis of subcutaneous (SQ) alemtuzumab induction therapy in highly sensitized patients desensitized with IVIG and rituximabA A Vo, E A Wechsler, J Wang, et al.
Transplantation|January 22, 2015
Factors Predicting Risk for Antibody-mediated Rejection and Graft Loss in Highly Human Leukocyte Antigen Sensitized Patients Transplanted After DesensitizationAshley A Vo, Aditi Sinha, Mark Haas, et al.
Clinical Journal of the American Society of Nephrology : CJASN|October 17, 2009
Acute hemolysis after high-dose intravenous immunoglobulin therapy in highly HLA sensitized patientsJoseph Kahwaji, Eva Barker, Sam Pepkowitz, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|September 10, 2005
Successful use of oral ganciclovir for the treatment of intrauterine cytomegalovirus infection in a renal allograft recipientD P Puliyanda, N S Silverman, D Lehman, et al.
Transplantation|March 21, 2013
Efficacy, outcomes, and cost-effectiveness of desensitization using IVIG and rituximabAshley A Vo, Jeffrey Petrozzino, Kai Yeung, et al.
G3 (Bethesda, Md.)|August 27, 2022
The mIAA7 degron improves auxin-mediated degradation in CaenorhabditiselegansJorian J Sepers, Noud H M Verstappen, An A Vo, et al.
Arquivos Brasileiros De Oftalmologia|August 10, 2022
Purtscher-like retinopathy in a patient with COVID-19-associated coagulopathyJoyce N Mbekeani, Nilesh K Raval, Thomas A Vo, et al.
Clinical Journal of the American Society of Nephrology : CJASN|August 21, 2007
Safety and adverse events profiles of intravenous gammaglobulin products used for immunomodulation: a single-center experienceAshley A Vo, Vinh Cam, Mieko Toyoda, et al.
Arthritis Care & Research|March 7, 2016
Functional Magnetic Resonance Imaging of Working Memory and Executive Dysfunction in Systemic Lupus Erythematosus and Antiphospholipid Antibody-Positive PatientsE Kozora, A M Uluğ, D Erkan, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|October 6, 2015
JC polyomavirus viremia and progressive multifocal leukoencephalopathy in human leukocyte antigen-sensitized kidney transplant recipients desensitized with intravenous immunoglobulin and rituximabM Toyoda, D Thomas, G Ahn, et al.
Pageof 15

Showing results (81-90 of 143) with videos related to

Sort By:
Pageof 15
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|November 2, 2007
Analysis of subcutaneous (SQ) alemtuzumab induction therapy in highly sensitized patients desensitized with IVIG and rituximabA A Vo, E A Wechsler, J Wang, et al.
Transplantation|January 22, 2015
Factors Predicting Risk for Antibody-mediated Rejection and Graft Loss in Highly Human Leukocyte Antigen Sensitized Patients Transplanted After DesensitizationAshley A Vo, Aditi Sinha, Mark Haas, et al.
Clinical Journal of the American Society of Nephrology : CJASN|October 17, 2009
Acute hemolysis after high-dose intravenous immunoglobulin therapy in highly HLA sensitized patientsJoseph Kahwaji, Eva Barker, Sam Pepkowitz, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|September 10, 2005
Successful use of oral ganciclovir for the treatment of intrauterine cytomegalovirus infection in a renal allograft recipientD P Puliyanda, N S Silverman, D Lehman, et al.
Transplantation|March 21, 2013
Efficacy, outcomes, and cost-effectiveness of desensitization using IVIG and rituximabAshley A Vo, Jeffrey Petrozzino, Kai Yeung, et al.
G3 (Bethesda, Md.)|August 27, 2022
The mIAA7 degron improves auxin-mediated degradation in CaenorhabditiselegansJorian J Sepers, Noud H M Verstappen, An A Vo, et al.
Arquivos Brasileiros De Oftalmologia|August 10, 2022
Purtscher-like retinopathy in a patient with COVID-19-associated coagulopathyJoyce N Mbekeani, Nilesh K Raval, Thomas A Vo, et al.
Clinical Journal of the American Society of Nephrology : CJASN|August 21, 2007
Safety and adverse events profiles of intravenous gammaglobulin products used for immunomodulation: a single-center experienceAshley A Vo, Vinh Cam, Mieko Toyoda, et al.
Arthritis Care & Research|March 7, 2016
Functional Magnetic Resonance Imaging of Working Memory and Executive Dysfunction in Systemic Lupus Erythematosus and Antiphospholipid Antibody-Positive PatientsE Kozora, A M Uluğ, D Erkan, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|October 6, 2015
JC polyomavirus viremia and progressive multifocal leukoencephalopathy in human leukocyte antigen-sensitized kidney transplant recipients desensitized with intravenous immunoglobulin and rituximabM Toyoda, D Thomas, G Ahn, et al.
Pageof 15